 | UK med-mj research: New Scientist: Multiple Sclerosis Trial |
ProgTeeTotall writes: "More details of the UK clinical trials emerged in New Scientist (15/11/03). Andy Coughlin summarises the outcome of the Lancet paper on multiple sclerosis and the analgesic effects of medical cannabis administered in a double-blind trial. Coughlin also notes different situations related to the medical marijuana debate in the United States, Canada and the United Kingdom
Source: Andy Coughlin "Limited Support for Medical Marijiuana" (p11) New Scientist, 15 November 2003
URL: http://www.newscientist.com"
|
|
|
|
| |
| Login |
|
You can register for some special extra features. | |
|